Compare SLVM & ENOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SLVM | ENOV |
|---|---|---|
| Founded | 1898 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Paper | Fluid Controls |
| Sector | Basic Materials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.4B |
| IPO Year | 2021 | 2008 |
| Metric | SLVM | ENOV |
|---|---|---|
| Price | $43.08 | $23.34 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 9 |
| Target Price | ★ $54.00 | $47.38 |
| AVG Volume (30 Days) | 270.4K | ★ 694.5K |
| Earning Date | 05-08-2026 | 05-07-2026 |
| Dividend Yield | ★ 4.15% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 3.24 | N/A |
| Revenue | ★ $3,351,000,000.00 | N/A |
| Revenue This Year | $0.93 | $6.36 |
| Revenue Next Year | $1.54 | $5.31 |
| P/E Ratio | $13.38 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $37.09 | $21.00 |
| 52 Week High | $61.31 | $36.82 |
| Indicator | SLVM | ENOV |
|---|---|---|
| Relative Strength Index (RSI) | 52.98 | 47.59 |
| Support Level | $41.08 | $21.52 |
| Resistance Level | $44.05 | $23.57 |
| Average True Range (ATR) | 1.52 | 1.32 |
| MACD | 0.19 | -0.21 |
| Stochastic Oscillator | 70.28 | 24.49 |
Sylvamo Corp is an uncoated papers company with a broad portfolio of top-tier brands and low-cost, large-scale paper mills. It produces uncoated freesheet (UFS) for paper products such as cut size and offset paper, as well as market pulp. The company offers Copy and Printer papers, Commercial Printing papers, Converting papers, and Specialty papers. It operates in three geographical segments: Europe, Latin America, and North America. Key revenue is generated from North America.
Enovis Corp is a medical technology manufacturer and distributor of medical devices used in reconstructive surgery, rehabilitation, pain management, and physical therapy. Its products support patient care from injury prevention through post-surgical or post-injury rehabilitation and treatment of degenerative conditions. The company's reportable segments include Prevention & Recovery and Reconstructive segments. The majority of revenueis derived from the Prevention & Recovery segment, which includes products that are used by orthopedic specialists, primary care physicians, physical therapists, chiropractors, athletic trainers and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformitiesand sports-related injuries.